The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away. By Madison Muller and Devin Leonard

The Caribbean Nation Unexpectedly Going Along With Trump’s Drug-Boat Narrative
13:32

Introducing: Bloomberg This Weekend
01:08

The Georgia Pastor Accused of Defrauding the VA of Nearly $24 Million
48:22